Does HPV Vaccination Lower Cancer Risk in Males? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Does HPV Vaccination Lower Cancer Risk in Males?

A large real-world study found a lower incidence of any HPV-related cancer among vaccinated males

  • By

  • Kerri Miller

  • April 17, 2026

  • 3 min

Share

Clinical Scorecard: Does HPV Vaccination Lower Cancer Risk in Males?

At a Glance

CategoryDetail
ConditionHPV-related cancers in males
Key Mechanisms9-valent HPV vaccine reduces cancer incidence
Target PopulationMales aged 9 to 26 years
Care SettingHealth care centers in the US

Key Highlights

  • Lower incidence of HPV-related cancers in vaccinated males compared to unvaccinated peers
  • Hazard ratio of 0.54 indicates a 46% lower risk of HPV-related cancer
  • Study included over 615,000 vaccinated and 2.3 million unvaccinated males
  • Findings support expanding sex-neutral HPV vaccination programs
  • Results primarily driven by head and neck cancer diagnoses

Guideline-Based Recommendations

Diagnosis

  • Cancer diagnoses based on administrative coding; caution due to potential misclassification

Management

  • Encourage HPV vaccination in males aged 9 to 26 years

Monitoring & Follow-up

  • Monitor cancer incidence and vaccination rates in targeted populations

Risks

  • Limitations include unaccounted risk factors and potential misclassification of vaccination status

Patient & Prescribing Data

Males aged 9 to 26 years

9-valent HPV vaccine is effective in reducing cancer risk

Clinical Best Practices

  • Administer HPV vaccines to both males and females
  • Promote awareness of HPV vaccination benefits in young males
  • Integrate HPV vaccination into routine adolescent health care

Related Resources & Content

Original Source(s)

Does HPV Vaccination Lower Cancer Risk in Males?

  • by Kerri Miller

  • April 17, 2026

Related Content

ACS report: Lung cancer deaths plunge as survival doubles

Lung cancer deaths fell by more than half among US males as smoking declined, earlier-stage diagnoses increased, and 5-year relative survival doubled.

Nasal obstruction may worsen OSA indicators

Increases in apnea-hypopnea events were greatest among patients with an elevated baseline index, while evidence supporting mouth taping remained preliminary.

What shapes patient attitudes toward TBP skin cancer screening?

Expert consensus highlights communication, privacy, and staff interactions as priorities for a proposed patient-reported experience measure.